State Of Wisconsin Investment Board Myovant Sciences Ltd. Transaction History

State Of Wisconsin Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$24.03 - $27.02 $744 - $837	31 Added 0.07%	43,283 $1.17 Million
Q3 2022 Nov 14, 2022	BUY	$11.6 - $20.44 $23,896 - $42,106	2,060 Added 5.0%	43,252 $777,000
Q2 2022 Aug 15, 2022	BUY	$7.78 - $14.69 $79,293 - $149,720	10,192 Added 32.88%	41,192 $512,000
Q1 2022 May 13, 2022	BUY	$11.38 - $16.4 $352,780 - $508,399	31,000 New	31,000 $413,000
Q2 2020 Aug 12, 2020	SELL	$7.34 - $20.84 $1.41 Million - $4.01 Million	-192,589 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.2 - $19.21 $292,756 - $1.34 Million	69,704 Added 56.72%	192,589 $2.99 Million
Q2 2019 Aug 14, 2019	BUY	$8.69 - $25.0 $1.07 Million - $3.07 Million	122,885 New	122,885 $1.11 Million

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.